Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M.B. Yunus, A.T. Masi, J.J. Calabro, K.A. Miller, S.L. Feigenbaum.
Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls.
Sent Arthritis Rheum, 11 (1981), pp. 151-171
[2.]
F. Wolfe, H.A. Smythe, M.B. Yunus, R. Bennett, C. Bombardier, D.L. Goldenberg, et al.
The American College of Rheumatology 1990 criteria for the classification of fibromyaldia.
Arthritis Rheum, 33 (1990), pp. 160-172
[3.]
H. Smythe.
"Fibrositis” and other diffuse musculoskeletal syndromes.
Textbook of rheumatology, pp. 489
[4.]
S.M. Campbell, S. Clark, E.A. Tindall, M.E. Forehand, R.M. Bennet.
Clinical characteristics of fibrositis: I. A blinded, controlled study of symptoms and tender points.
Arthritis Rheum, 26 (1983), pp. 817-824
[5.]
D.L. Goldenberg.
Desafíos en el diagnóstico y tratamiento de la fibromialgia.
Hospital Practice (ed. esp.), 5 (1990), pp. 23-29
[7.]
M.D. Boissevain, G.A. McCain.
Toward an integrated understanding of fibromyalgia syndrome.
I Medical and pathophysiological aspects. Pain, 45 (1991), pp. 227-238
[8.]
E. Houvenagel.
La fibromyalgie: concepts pathogeniques.
Rev Rhum Mal Osteóartic, 60 (1993), pp. 223-228
[9.]
D.L. Goldenberg.
Phychological symptoms and psychiatric diagnosis in patients with fibromyalgia.
J Rheumatol, 16 (1989), pp. 127-130
[10.]
J.I. Hudson, H.G. Pope.
Fibromyalgia and psychopathology: is fibromyalgia a form of affective spectrum disorder?.
J Rheumatol, 16 (1989), pp. 15-22
[11.]
M.B. Yunus.
Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanism with peripheral modulation.
J Rheumatol, 19 (1992), pp. 846-850
[12.]
G. Ferraccioli, F. Cavalieri, F. Salaffi, S. Fontana, F. Scita, M. Nolli, D. Maestri.
Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and other chronic rheumatic conditions (rheumatoid arthritis, low back pain).
J Rheumatol, 17 (1990), pp. 869-873
[13.]
R.M. Bennett, J.R. Clark, S.M. Campbell, C.S. Burckhardt.
Low levels of somatomedin C in patients with fibromyalgia syndrome: a possible link betwen sleep and muscle pain.
Arthritis Rheum, 35 (1992), pp. 1.113-1.116
[14.]
N. Hader, D. Rimon, A. Kinarty, N. Lahat.
Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome.
Arthritis Rheum, 34 (1991), pp. 866-872
[15.]
R. Klein, M. Bansch, P.A. Berg.
Clinical relevance of antibodies against serotonin and gangliosides in patients with fibromyalgia syndrome.
Psichoneuroendocrinology, 17 (1992), pp. 593-598
[16.]
W. Hernanz, A. Valenzuela, J. Quijada, A. Garcia, J.L. De La Iglesia, A. Gutiérrez, et al.
Lymphocite .subpopulations in patients with primary fibromyalgia.
J Rheumatol, 21 (1994), pp. 2.122-2.124
[17.]
K.G. Henriksson, A. Bengtsson.
Muscle biopsy findings of possible diagnostic importance in primary fibromyalgia (fibrositis, myofascial syndrome).
Lancet, 2 (1982), pp. 1.395
[18.]
M.B. Yunus, U.P. Kalyan-Raman, K. Kalyan-Raman, A.T. Masi.
Pathologic changes in muscle in primary fibromyalgia syndrome.
Am J Med, 81 (1986), pp. 38-42
[19.]
H. Moldofsky, P. Scarisbrick, R. England, H. Smythe.
Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects.
Psychosom Med, 37 (1975), pp. 341-351
[20.]
H. Moldofsky, P. Scarisbrick.
Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation.
Psychosom Med, 38 (1976), pp. 35-44
[21.]
J.C. Ware, J. Russell, E. Campos.
Alpha intrusions into the sleep of depressed and fibromyalgia syndrome (fibrositis) patients.
Sleep Res, 15 (1986), pp. 210
[22.]
J. Branco, A. Atalaia, T. Paiva.
Sleep cycles and alpha-delta sleep in fibromyalgia syndrome.
J Rheumatol, 21 (1994), pp. 1.113-1.117
[23.]
A.M. Anch, F.A. Lue, A.W. McLean, H. Moldofsky.
Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome.
Can J Psychol, 45 (1991), pp. 179-184
[24.]
A.M. Drewes, L. Svendsen, K.D. Nielsen, S.J. Taagholt, K. Bjerregard.
Quantification of alpha-EEG activity in fibromyalgia: A study based on ambulatory sleep monitoring.
J Musculoskeletal Pain, 2 (1994), pp. 33-53
[25.]
P. Hauri, D.R. Hawkins.
Alpha-delta sleep.
Electroenceph Clin Neurophysiol, 24 (1973), pp. 233-237
[26.]
W. Scheuler, S. Kubicki, J. Marquardt.
The alpha sleep patternquantitative analysis and functional aspects.
Sleep ’86, pp. 86
[28.]
P. Saskin, H. Moldofsky, F. Lue.
Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome).
Psychosom Med, 48 (1986), pp. 319-323
[29.]
R.R. Molony, D.M. McPeek, P.L. Schiffman, M. Frank, J.A. Neubaver, M. Schwartzberg, J.R. Seibold.
Sleep, sleep apnea and the fibrositis syndrome.
J Rheumatol, 13 (1986), pp. 797-800
[30.]
H. Moldofsky, F.A. Lue, H.A. Smythe.
Sleep and morning symptoms in rheumatoid arthritis.
J Rheumatol, 10 (1983), pp. 373-379
[31.]
H. Moldofsky, F.A. Lue, P. Saskin.
Sleep and morning pain in primary osteoarthritis.
J Rheumatol, 14 (1987), pp. 124-128
[32.]
B. Gudbjörnsson, J.E. Broman, J. Hetta, R. Hällgren.
Sleep disturbances in patients with primary Sjogren's syndrome.
Br J Rheumatol, 32 (1993), pp. 1.072-1.076
[33.]
H. Moldofsky, C. Tullis, F.A. Lu.
Sleep related myoclonus in rheumatic pain modulation disorder (fibrositis syndrome).
J Rheumatol, 13 (1986), pp. 614-617
[34.]
K.P. May, S.G. West, M.R. Baker, D.W. Everett.
Sleep apnea in male patients with the fibromyalgia syndrome.
Am J Med, 94 (1993), pp. 505-508
[35.]
H. Moldofsky, P. Saskin, F.A. Lue.
Sleep and symptoms in fibrositis syndrome after a febrile illness.
J Rheumatol, 15 (1988), pp. 1.701-1.704
[36.]
H. Moldofsky.
Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndrome.
J Rheumatol, 16 (1989), pp. 150-153
[37.]
M. Gupta, H. Moldofsky.
Dysthymic disorder and rheumatic pain modulation disorder (fibrositis syndrome): a comparison of symptoms and sleep physiology.
Can J Psychiat, 31 (1986), pp. 608-616
[38.]
J.A. Horne, B.S. Shackell.
Alpha-like activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome.
Electroencephalogr Clin Neurophysiol, 79 (1991), pp. 271-276
[39.]
M. Doherty, J. Smith.
Elusive “alpha-delta” sleep in fibromyalgia and osteoarthritis (letter).
Ann Rheum Dis, 52 (1993), pp. 245
[40.]
S. Carette, G. Oakson, C. Guimont, M. Steriade.
Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia.
Arthritis Rheum, 38 (1995), pp. 1.211-1.217
[41.]
W. Scheuler, P. Rappelsberger, F. Schmartz, C. Pastelak-Price, H. Petche, S. Kubicki.
Periodicity analysis of sleep EEG in the second and minute ranges-examples of application in different alpha activities in sleep.
Electroencefalogr Clin Neurophysiol, 76 (1990), pp. 222-234
[42.]
H.A. Smythe.
Studies of sleep in fibromyalgia; techniques, clinical significance, and future directions.
Br J Rheumatol, 34 (1995), pp. 897-900
[43.]
A.M. Drewes, K.D. Nielsen, S.J. Taagholt, K. Bjerregard, L. Svendsen, J. Gade.
Sleep intensity in fibromyalgia: Focus on the microstructure of the sleep process.
Br J Rheumatol, 34 (1995), pp. 629-635
[44.]
S.A. Older, C.L. Danning, D.F. Battafarano, J.A. Ward, E.P. Grady.
Delta wave sleep suppression and fibromyalgia symptoms in healthy subjects: a preliminary reappraisal of the Moldofsky hypothesis [resumen].
Arthritis Rheum, 34 (1994), pp. 348
[45.]
I. Feinberg, T.C. Floyd.
Systematic trends across the night in human sleep cycles.
Psychophysiology, 16 (1979), pp. 283-291
[46.]
P. Jennum, A.M. Drewes, A. Andreasen, K.D. Nielsen.
Sleep and other symptoms in primary fibromyalgia and healthy controls.
J Rheumatol, 20 (1993), pp. 1.756-1.759
[47.]
S. Carette, G.A. McCain, D.A. Bell, A.G. Fam.
Evaluation of amytriptyline in primary fibrositis.
Arthritis Rheum, 29 (1986), pp. 655-659
[48.]
R. Jaeschke, J. Adachi, G. Guyatt, J. Keller, B. Wong.
Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials.
J Rheumatol, 18 (1991), pp. 447-451
[49.]
S. Carette, M.J. Bell, W.J. Reynolds, B. Haraoui, G.A. McCain, V.P. Bykers, et al.
Comparison of amitriptyline, ciclobenzaprine and placebo in the treatment of fibromyalgia.
Arthritis Rheum, 37 (1994), pp. 32-40
[50.]
D.L. Goldenberg.
Psychiatric and psychologic aspects of fibromyalgia syndrome.
Rheum Dis Clin North Am, 15 (1989), pp. 105-114
[51.]
D.L. Goldenberg.
Treatment of fibromyalgia syndrome.
Rheum Dis Clin North Am, 15 (1989), pp. 61-71
[52.]
I.J. Russell.
Neurohormonal aspects of fibromyalgia syndrome.
Dis Rheum Clin North Am, 15 (1989), pp. 149-169
[53.]
B.A. Jones.
The sleep-wake cycle: basic mechanism.
J Rheumatol, 16 (1989), pp. 49-51
[54.]
B. Cortet, E. Houvenagel, G. Forzy, G. Vincent, B. Delcambre.
Evaluation de l’efficacité d’un traitment sérotoninergique (chlorhydrate de fluoxétine au cours de la fibromyalgie).
Rev Rhum Mal Ostéoartic, 59 (1992), pp. 497-500
[55.]
A.T. Masi, M.B. Yunus.
Fibromyalgia -which is the best treatment?. A personalized comprehensive, ambulatory, patient-involved management programme.
Bailliere's Clin Rheumatol, 4 (1990), pp. 333-370
[56.]
M.B. Yunus, J.C. Aldag.
Restless legs syndrome and leg cramps in fibromyalgia syndrome. A controlled study.
Br Med J, 312 (1996), pp. 1.339
[57.]
J.I. Hudson, D.L. Goldenberg, H.G. Pope Jr., P.E. Keck Jr., L. Schlesinger.
Comorbidity of fibromyalgia with medical and psychiatric disorders.
Am J Med, 92 (1992), pp. 363-367
[58.]
P. Disdier, P. Genton, C. Milandre, P.M. Bernard, Y. Millet.
Fibrositis syndrome and narcolepsy.
J Rheumatol, 20 (1993), pp. 888-889
[59.]
H. Moldofsky, C. Tullic, F.A. Lu, G. Quance, J. Davidson.
Sleep-related myoclonus in rheumatic pain modulation disorder (fibrositis syndrome) and in excessive daytime somnolence.
Psychosom Med, 46 (1984), pp. 145-151
[60.]
J.W. Shepard.
Physiologic and clinical consequences of sleep apnea.
Sem Res Med, 9 (1988), pp. 560-568
[61.]
P.L. Smith.
Evaluation of patients with sleep disorders.
Sem Resp Med, 9 (1988), pp. 534-539
[62.]
B. Alvarez Lario, J. Terán, J.L. Alonso, J. Alegre, I. Arroyo, J.L. Viejo.
Lack of association between fibromyalgia and sleep apnea syndrome.
Ann Rheum Dis, 51 (1992), pp. 108-111
[63.]
F. Donald, J.M. Esdaile, J.R. Kimoff, M.A. Fitzcharles.
Musculoskeletal complaints and fibromyalgia in patients attending a respiratory sleep disorders clinic.
J Rheumatol, 23 (1996), pp. 1.612-1.616
[64.]
B. Alvarez Lario, J.L. Alonso Valdivielso, J. Alegre López, C. Martel Soteres, J.L. Viejo Banuelos, A. Marañón Cabello.
Fibromyalgia syndrome: overnight falls in arterial oxygen saturation.
Am J Med, 101 (1996), pp. 54-60
[65.]
B. Álvarez Lario, J. Alegre López, J.L. Alonso Valdivielso, J. Terán, J.L. Viejo.
Epworth sleepiness scale in fibromyalgia syndrome [resumen].
Rheumatol Eur, 24 (1995), pp. 158
[66.]
M.W. Johns.
A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.
Sleep, 14 (1991), pp. 540-545
[67.]
M.W. Johns.
Reliability and factor analysis of the Epworth Sleepiness Scale.
Sleep, 15 (1992), pp. 376-381
[68.]
M.W. Johns.
Daytime sleepiness, snoring and obstructive sleep apnea.
The Epworth Sleepiness Scale. Chest, 103 (1993), pp. 30-36
[69.]
M. Lurie, K. Caidahl, G. Johansson, B. Bake.
Respiratory function in chronic primary fibromyalgia.
Scand J Rehabil Med, 22 (1990), pp. 151-155
[70.]
T. Gislasson, M. Almqvist, G. Boman, C.E. Lindholm, L. Terenius, C.S.F. Increased.
opioid activity in sleep apnea syndrome. Regression after successful treatment.
Chest, 96 (1989), pp. 250-254
[71.]
H.E. Greenberg, D.M. Rapoport, S.A. Rothenberg, L.A. Kanensiger, R.G. Norman, R.M. Goldring.
Endogenous opiates modulate the postapnea ventilatory response in the obstructive sleep apnea syndrome.
Am Rev Respir Dis, 143 (1991), pp. 1.282-1.287
[72.]
A. Bengtsson, K.G. Henriksson, J. Larsson.
Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia.
Arthritis Rheum, 29 (1986), pp. 817-821
Copyright © 1997. Sociedad Española de Neumología y Cirugía Torácica
